# Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/spironolactone-versus-placebo-bisoprolol-and-doxazosin-to-determine-the-optimal/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Bryan Williams,Thomas M. MacDonald,S. V. Morant,David J Webb,Peter Sever,Gordon T. McInnes,Ian Ford,J. CRUICKSHANK,Mark J. Caulfield,Jackie Salsbury,Isla S. Mackenzie,Sandosh Padmanabhan,Morris J. Brown |
| Citations | 1,273 |
| DOI | 10.1016/s0140-6736(15)00257-3 |
| Fields | Medicine,Nursing |
| Open Access | true |
| OA Status | hybrid |
| OA URL | http://www.thelancet.com/article/S0140673615002573/pdf |
| OpenAlex ID | https://openalex.org/W1797367453 |
| PMID | 26414968 |
| Type | article |
| Year | 2015 |

## Paper authors

- [Bryan Williams](https://scholariq.org/researchers/bryan-williams/)
- [Ian Ford](https://scholariq.org/researchers/ian-ford/)

## Paper journal

- [The Lancet](https://scholariq.org/journals/the-lancet/)

## Paper primary topic

- [Hormonal Regulation and Hypertension](https://scholariq.org/topics/hormonal-regulation-and-hypertension/)

## Paper topics

- [Hormonal Regulation and Hypertension](https://scholariq.org/topics/hormonal-regulation-and-hypertension/)
- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Sodium Intake and Health](https://scholariq.org/topics/sodium-intake-and-health/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.